Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1396157 | 0.89 | MAPK1 (0.35) | MAPK1MCL1THRBSRD5A2 | |
| SCHEMBL11528758 | 0.81 | MCL1 (0.42) | MAPK1MCL1CYP1A2RECQLCA1 | |
| SCHEMBL17438623 | 0.79 | MCL1 (0.41) | MAPK1MCL1CYP1A2RECQLCA1 | |
| SCHEMBL19086466 | 0.79 | MCL1 (0.34) | MCL1THRBSRD5A2 | |
| SCHEMBL725764 | 0.76 | MCL1 (0.49) | MAPK1MCL1KDM4EHSD17B10CA1 | |
| SCHEMBL779699 | 0.73 | ALDH1A1 (0.48) | KDM4E | |
| SCHEMBL374935 | 0.73 | MAPK1 (0.47) | MAPK1MCL1THRBCYP1A2RECQL | |
| SCHEMBL31276435 | 0.73 | MAPK1 (0.47) | MAPK1MCL1THRBCYP1A2RECQL | |
| SCHEMBL25061 | 0.73 | MAPK1 (0.47) | MAPK1MCL1THRBCYP1A2RECQL | |
| SCHEMBL20292477 | 0.73 | TSPO (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2306994-A1 | S1P1 RECEPTOR AGONISTS AND USE THEREOF | Amgen, Inc (US) | 2011-04-13 | — | — | EP | disclosed |
| WO-2009154775-A1 | S1P1 RECEPTOR AGONISTS AND USE THEREOF | AMGEN INC. (US) | 2009-12-23 | — | — | WO | disclosed |
| EP-1773338-A4 | ACYLATED PIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS | MERCK & CO INC (US) | 2007-08-01 | — | — | EP | disclosed |
| EP-1773338-A2 | ACYLATED PIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS | Merck & Co., Inc. (US) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006020277-A2 | ACYLATED PIPERIDINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR AGONISTS | MERCK & CO., INC. (US) | 2006-02-23 | — | — | WO | disclosed |